---
accession : E-MEXP-2104
platform  : A-AGIL-28
pathway   : Hypoxia
cells     : human monocytes and monocyte-derived macrophages (with CSF-1)
treatment : 1% oxygen
effect    : activating
hours     : 24

control   :
    - D10N_720
    - D1N_A
    - D10N_B
    - D10N_810
    - D10N_A
perturbed :
    - D1H_810
    - D1H_A
    - D10H_A
    - D10H_720
    - D10H_B
    - D1H_B
    - D10H_810
    - d1H_720
...
